Sirnaomics, which counts Walvax Bio, China Resources Group and Charoen Pokphand Group as existing investors, has raised series E funding to advance its drug development activities.

Accenture, Chevron, ConocoPhillips, General Electric, Intel, Shell and Saudi Aramco have all exited the operations management software provider in a purchase by SparkCognition.

JetBlue Technology Ventures has appointed Amy Burr as successor to previous president Bonny Simi, who has transitioned into an advisory role.

GV helped geometric search technology developer Physna raise $56m while multiple corporates took part in a round nearly doubling study app developer Mathpresso's total funding to $105m.

Alphabet and Roc Nation are in line for exits as the online trading platform operator prepares for a flotation potentially valuing it at $40bn.

The healthcare management software developer, previously backed by GV and Ascension Ventures, has taken its overall funding past $900m.

SoftBank has supplied the entirety of the cryptocurrency exchange operator's series B round, which valued its parent company 2TM Group at $2.1bn.

NTT Docomo, Capital One and Phoenix Insurance could exit the fraud detection software provider, which has announced its intention to float on the New York Stock Exchange.

Novo-backed Procept BioRobotics has secured series G funding to further commercialise its surgical robotic system.

Lilly Asia Ventures is among the participants in a series A round for the lung cancer drug developer that could potentially reach $150m.